Meiji Holdings Co., Ltd.

Tokyo Stock Exchange 2269.T

Meiji Holdings Co., Ltd. Debt to Equity Ratio for the year ending March 31, 2024: 0.07

Meiji Holdings Co., Ltd. Debt to Equity Ratio is 0.07 for the year ending March 31, 2024, a -26.04% change year over year. Debt to equity ratio represents the financing from debt versus equity. Higher ratio indicates more debt reliance, suggesting potential risk.
  • Meiji Holdings Co., Ltd. Debt to Equity Ratio for the year ending March 31, 2023 was 0.09, a -25.08% change year over year.
  • Meiji Holdings Co., Ltd. Debt to Equity Ratio for the year ending March 31, 2022 was 0.12, a -26.31% change year over year.
  • Meiji Holdings Co., Ltd. Debt to Equity Ratio for the year ending March 31, 2021 was 0.16, a -13.67% change year over year.
  • Meiji Holdings Co., Ltd. Debt to Equity Ratio for the year ending March 31, 2020 was 0.19, a -14.04% change year over year.
Key data
Date Debt to Equity Ratio Debt to Income Ratio Debt to Tangible Net Worth Ratio Dividend Coverage Ratio
Market news
Loading...
SV Wall Street
Tokyo Stock Exchange: 2269.T

Meiji Holdings Co., Ltd.

CEO Mr. Kazuo Kawamura
IPO Date Jan. 4, 2000
Location Japan
Headquarters 2-4-16, Kyobashi
Employees 17,270
Sector Consumer Staples
Industries
Description

Meiji Holdings Co., Ltd., through its subsidiaries, manufactures and sells dairy products, confectioneries, nutritional products, and pharmaceuticals in Japan and internationally. The company operates through two segments, Food and Pharmaceutical. It provides yogurt, drinking milk, beverages, cheese, butter and margarine, cream, ice cream, frozen foods, chocolates, gummy products, chewing gums, candies, sports nutrition products, infant and eternal formula, beauty supplements, OTC drugs, livestock products, and sugar, as well as transportation and distribution services. The company also provides drugs for infectious diseases and central nervous system disorders, as well as generic drugs; agricultural and livestock chemicals; human and veterinary vaccines, and blood plasma products; and veterinary drugs for livestock and fisheries comprising antimicrobial injection, oral administration, antipyretic, analgesic, anti-inflammatory, hemostatic, and breeding agents, disinfectants, insecticides, anthelmintics, metabolites, feed additives, and mixed feed; and companion animals, including anesthetics and painkillers, anti-parasitic and gastrointestinal drugs, anti-bacterial agents, antiplasmin agents, vitamin E preparations, and dietary supplements. Meiji Holdings Co., Ltd. was founded in 1916 and is headquartered in Tokyo, Japan.

Similar companies

4452.T

Kao Corporation

USD 40.06

1.03%

2502.T

Asahi Group Holdings, Ltd.

USD 11.00

1.12%

2503.T

Kirin Holdings Company, Limited

USD 12.79

0.51%

2801.T

Kikkoman Corporation

USD 10.66

0.74%

2802.T

Ajinomoto Co., Inc.

USD 40.60

1.22%

StockViz Staff

January 31, 2025

Any question? Send us an email